Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Biden urges Congress to fund ARPA-H as OSTP nominee Eric Lander defines agency’s mission

Biden urges Congress to fund ARPA-H as OSTP nominee Eric Lander defines agency’s mission

April 30, 2021
Vol.47 No.17
By Matthew Bin Han Ong
We ask MIT’s Vander Heiden to delineate science from engineering—and NCI from ARPA-H
Conversation with The Cancer Letter

We ask MIT’s Vander Heiden to delineate science from engineering—and NCI from ARPA-H
“The lines are much more blurred in terms of what’s an engineering problem and what’s a basic science problem.”

April 23, 2021
Vol.47 No.16
By Matthew Bin Han Ong and Paul Goldberg
Chernobyl: a 35 year follow up on long-term health effects
Cancer History ProjectFreeGuest Editorial

Chernobyl: a 35 year follow up on long-term health effects

April 23, 2021
Vol.47 No.16
By Robert Peter Gale
Sharpless: ARPA-H and NCI should help each other to “end cancer as we know it”
NCI

Sharpless: ARPA-H and NCI should help each other to “end cancer as we know it”

April 16, 2021
Vol.47 No.15
By Matthew Bin Han Ong
The Moonshot’s Metric for Success: Avoiding a Single, Tangible Endpoint
Free

The Moonshot’s Metric for Success: Avoiding a Single, Tangible Endpoint

June 24, 2016
Vol.42 No.25

Posts navigation

Previous1…3839

Trending Stories

  • OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
  • Peter F. Garrett to people with cancer: Your story has power
  • What NHS-Galleri taught us—and what it didn’t
  • As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
    The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded
  • The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
  • Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
    “The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account